Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123346
Filing Date
2024-11-07
Accepted
2024-11-07 16:13:07
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20240930.htm   iXBRL 10-Q 1631349
2 EX-10.1 tyra-ex10_1.htm EX-10.1 237561
3 EX-10.2 tyra-ex10_2.htm EX-10.2 173941
4 EX-31.1 tyra-ex31_1.htm EX-31.1 16417
5 EX-31.2 tyra-ex31_2.htm EX-31.2 16599
6 EX-32.1 tyra-ex32_1.htm EX-32.1 8946
7 EX-32.2 tyra-ex32_2.htm EX-32.2 8909
  Complete submission text file 0000950170-24-123346.txt   7504450

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20240930.xsd EX-101.SCH 999060
66 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20240930_htm.xml XML 1297458
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 241435854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)